Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Research Use Only Not for human consumption or medical applications
Primary peptide: KPV at 200 to 400 mcg subcutaneously daily Support peptide: Thymosin alpha-1 at 1.6 mg subcutaneously twice weekly Implementation schedule: Pre-season (4 weeks before): Begin KPV daily and Ta1 twice weekly to stabilize mast cells and rebalance Th1/Th2 ratio before allergen exposure peaks During season: Continue both peptides at the same doses throughout the allergy season Post-season: Taper KPV over 2 weeks
Its a simple, safe, and effective way to revitalize your body and mind
BPC-157 Thymosin Beta 4 reduces inflammation and oxidative stress, protects neurons, and promotes tissue repair, cell migration, thereby promoting the health of the nervous system
Needle length for subcutaneous injection should be 12.7mm (1/2 inch) for most individuals
Research has shown that BPC 157: Influences dopaminergic pathways, potentially improving motivation, focus, and cognitive function Interacts with serotonergic systems, which may contribute to mood stability and emotional resilience Has shown protective effects in animal models of traumatic brain injury, suggesting it may support neural tissue integrity May assist in nerve regeneration after damage, based on studies examining peripheral nerve injuries Could support the blood-brain barrier, the selective filter that protects the brain from harmful substances Some users report deeper sleep, improved focus, and emotional resilience while using BPC 157 peptide
